Efficacy of lifestyle interventions in physical health management of patients with severe mental illness

被引:0
作者
Fernando Chacón
Fernando Mora
Alicia Gervás-Ríos
Inmaculada Gilaberte
机构
[1] Lilly SA,Clinical Research Department
[2] Hospital Infanta Leonor,Servicio de Psiquiatría
来源
Annals of General Psychiatry | / 10卷
关键词
Schizophrenia; Metabolic Syndrome; Metformin; Bipolar Disorder; Smoking Cessation;
D O I
暂无
中图分类号
学科分类号
摘要
Awareness of the importance of maintaining physical health for patients with severe mental illnesses has recently been on the increase. Although there are several elements contributing to poor physical health among these patients as compared with the general population, risk factors for cardiovascular disease such as smoking, diabetes mellitus, hypertension, dyslipidemia, metabolic syndrome, and obesity are of particular significance due to their relationship with mortality and morbidity. These patients present higher vulnerability to cardiovascular risk factors based on several issues, such as genetic predisposition to certain pathologies, poor eating habits and sedentary lifestyles, high proportions of smokers and drug abusers, less access to regular health care services, and potential adverse events during pharmacological treatment. Nevertheless, there is ample scientific evidence supporting the benefits of lifestyle interventions based on diet and exercise designed to minimize and reduce the negative impact of these risk factors on the physical health of patients with severe mental illnesses.
引用
收藏
相关论文
共 527 条
[51]  
Maj M(2006)A comprehensive review of behavioral interventions for weight management in schizophrenia Ann Clin Psychiatry 18 23-542
[52]  
Green AI(2007)Second-generation antipsychotic exposure and metabolic-related disorders in patients with schizophrenia: an observational pharmacoepidemiology study from 1988 to 2002 J Clin Psychopharmacol 27 46-495
[53]  
Drake RE(2008)Non-pharmacological management of antipsychotic-induced weight gain: systematic review and meta-analysis of randomised controlled trials Br J Psychiatry 193 101-S11
[54]  
Brunette MF(2009)Contributing factors to weight gain during long-term treatment with second-generation antipsychotics. A systematic appraisal and clinical implications Obes Rev 10 527-82
[55]  
Noordsy DL(2008)Pharmacological management of atypical antipsychotic-induced weight gain CNS Drugs 22 477-14
[56]  
Green AI(2009)Obesity: why be concerned? Am J Med 122 S4-1645
[57]  
Brown ES(2009)The incidence of co-morbidities related to obesity and overweight: a systematic review and meta-analysis BMC Public Health 9 88-S30
[58]  
Goff DC(2010)Prevalence of cardiovascular risk factors and disease in people with schizophrenia: a population-based study Schizophr Res 117 75-29
[59]  
Cather C(2009)The metabolic syndrome and schizophrenia Acta Psychiatr Scand 119 4-S177
[60]  
Evins AE(2009)The relation of metabolic syndrome according to five definitions to cardiovascular risk factors - a population-based study BMC Public Health 9 484-518